Status:

COMPLETED

Evaluation of CureXcell® in Treating Lower Extremity Chronic Ulcers in Adults With Diabetes

Lead Sponsor:

Macrocure Ltd.

Collaborating Sponsors:

Amarex Clinical Research

ICON plc

Conditions:

Lower Extremity Chronic Ulcers in Diabetics

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Chronic foot ulcers are particularly prevalent in patients with underlying diabetes mellitus. These ulcers are reported to be the leading cause of hospitalization among people with diabetes. The purp...

Detailed Description

Chronic foot ulcers are particularly prevalent in patients with underlying diabetes mellitus. The prevalence of diabetes mellitus is growing at epidemic rates in Europe, United States and in general w...

Eligibility Criteria

Inclusion

  • Males or females at least 18 years of age with diabetes type 1 or type 2;
  • Patients with HbA1c ≤ 12%;
  • Patients with at least one lower extremity (on or below the malleolus (ankle bone)), at least full-thickness ulcer (penetrating through the whole layer of the skin), which has been unresponsive to any treatment for at least 4 weeks;
  • Ulcers with an area between ≥ 1 cm2 and ≤ 20 cm2 (after sharp debridement of free, non-viable, hyperkeratotic and fibrotic tissue to the extent possible);
  • Ankle Brachial Index ≥ 0.65;

Exclusion

  • Patients with more than two ulcers on the same foot or more than a total of three chronic ulcers;
  • Patients with ulcers primarily caused by venous insufficiency;
  • Patients whose target ulcer has decreased \> 25% in size from screening to baseline;
  • Malignancy within the past 5 years excluding successfully treated basal cell carcinoma;
  • Significantly compromised immunity for any reason including radiation therapy, chemotherapy or HIV;
  • Current clinical osteomyelitis;
  • Acute Charcot foot;
  • Current sepsis;

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2015

Estimated Enrollment :

285 Patients enrolled

Trial Details

Trial ID

NCT01421966

Start Date

August 1 2011

End Date

October 1 2015

Last Update

December 7 2015

Active Locations (37)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (37 locations)

1

Glendale, Arizona, United States

2

Mesa, Arizona, United States

3

Phoenix, Arizona, United States

4

Tucson, Arizona, United States